Pathophysiological study of chronic subdural hematoma and communicating hydrocephalus with delayed MRI using Gd-DTPA (Magnevist)
Creators
- 1. National Medical Center of Hospital, Tokyo (Japan)
Description
Concerning the pathophysiology of chronic subdural hematoma and communicating hydrocephalus, recent studies have been made, but no definitive conclusion has yet been attained. To study their complicated mechanisms, we examined a delayed MRI which was performed 4 hours after the intravenous injection of Gd-diethylenetriaminepentaacetic acid (Gd-DTPA) on 5 cases of subdural hygroma, 3 cases of chronic subdural hematoma after irrigation, one case of hydrocephalus with glioblastoma, and one case of Parkinson syndrome. In every case of subdural hygroma, it was certified that Gd-DTPA was leaked into the cavity of the subdural space. This is perhaps because the outer and inner membranes of the subdural hygroma consist of fibroblasts and of capillary vessels with fenestration; the leakage of blood composition through this fenestration may promote the growth of the membrane and the cavity. The leakage of Gd-DTPA decreased after irrigation, and it did not recur. In the case of hydrocephalus with gioblastoma, there was leakage of Gd-DTPA into the ventricles surrounding the tumor. This may be because of the destruction of the blood-cerebrospinal fluid barrier; perhaps this is associated with the cause of the communicating hydrocephalus. (author)
Additional details
Publishing Information
- Journal Title
- CT Kenkyu
- Journal Volume
- 13
- Journal Issue
- 3
- Series
- CT Kenkyu.
- Journal Page Range
- 305-311
- ISSN
- 0387-8015
- CODEN
- CTKED
INIS
- Country of Publication
- Japan
- Country of Input or Organization
- Japan
- INIS RN
- 23039475
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- CEREBRUM; CONTRAST MEDIA; DTPA; EDEMA; GADOLINIUM COMPLEXES; HEMORRHAGE; MALFORMATIONS; MENINGES; NMR IMAGING; TIME DEPENDENCE
- Descriptors DEC
- AMINO ACIDS; BODY; BRAIN; CARBOXYLIC ACIDS; CENTRAL NERVOUS SYSTEM; CHELATING AGENTS; COMPLEXES; DIAGNOSTIC TECHNIQUES; DISEASES; DRUGS; MEMBRANES; NERVOUS SYSTEM; ORGANIC ACIDS; ORGANIC COMPOUNDS; ORGANS; PATHOLOGICAL CHANGES; RADIOPROTECTIVE SUBSTANCES; RARE EARTH COMPLEXES; RESPONSE MODIFYING FACTORS; SYMPTOMS